Panos Karagiannis

Panos is a consultant in medical oncology and hematology and is holds a PhD from King’s College London in immunology. His research during his PhD included understanding and modulating the adaptive immune response. He discovered a IgG4-mediated tumor evasion mechanism in melanoma and design severely tools to identify tumor antigen specific antibodies which are currently being tested in preclinical applications. During his residency in Oncology at the University Medical Center Hamburg-Eppendorf Panos' research focus was on B cell in solid cancers and the immune modulation in the tumor microenvironment where he supported his fellow lab colleague in several translation projects. Panos joined the Fischer Lab to deepen his knowledge of target degradation and protein design and to explore the identification of novel mechanisms to modulate the immune system in the tumor microenvironment.